Captor Therapeutics Spolka Akcyjna (CTX.WA)

PLN 33.9

(-4.24%)

Net Debt Summary of Captor Therapeutics Spolka Akcyjna

  • Captor Therapeutics Spolka Akcyjna's latest annual net debt in 2023 was -71.92 Million PLN , down -12.24% from previous year.
  • Captor Therapeutics Spolka Akcyjna's latest quarterly net debt in 2024 Q2 was -50.17 Million PLN , up 19.11% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported annual net debt of -64.08 Million PLN in 2022, up 41.62% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported annual net debt of -109.76 Million PLN in 2021, down -6225.11% from previous year.
  • Captor Therapeutics Spolka Akcyjna reported quarterly net debt of -62.01 Million PLN for 2024 Q1, up 13.77% from previous quarter.
  • Captor Therapeutics Spolka Akcyjna reported quarterly net debt of -33.92 Million PLN for 2023 Q3, up 3.77% from previous quarter.

Annual Net Debt Chart of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Historical Annual Net Debt of Captor Therapeutics Spolka Akcyjna (2023 - 2017)

Year Net Debt Net Debt Growth
2023 -71.92 Million PLN -12.24%
2022 -64.08 Million PLN 41.62%
2021 -109.76 Million PLN -6225.11%
2020 1.79 Million PLN 187.07%
2019 -2.05 Million PLN -124.47%
2018 8.4 Million PLN 574.34%
2017 1.24 Million PLN 0.0%

Peer Net Debt Comparison of Captor Therapeutics Spolka Akcyjna

Name Net Debt Net Debt Difference
Bioceltix S.A. -9.13 Million PLN -687.348%
BIOTON S.A. 64.81 Million PLN 210.98%
Mabion S.A. -11.98 Million PLN -499.933%
Molecure S.A. -56.84 Million PLN -26.522%
NanoGroup S.A. -537.61 Thousand PLN -13278.794%
Pharmena S.A. -22.05 Million PLN -226.106%
Poltreg S.A. -57.75 Million PLN -24.532%
Pure Biologics Spólka Akcyjna 9.33 Million PLN 870.746%
Ryvu Therapeutics S.A. -57.03 Million PLN -26.113%
Synthaverse S.A. 67.86 Million PLN 205.979%
Urteste S.A. -512 Thousand PLN -13948.047%